These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11212490)

  • 1. [Recombinant human erythropoietin--blood transfusion alternative].
    Morshakova EF
    Antibiot Khimioter; 2000; 45(12):27-9. PubMed ID: 11212490
    [No Abstract]   [Full Text] [Related]  

  • 2. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
    Nissenson AR
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia management in chronic kidney disease: role of factors affecting epoetin responsiveness.
    Eschbach JW
    J Am Soc Nephrol; 2002 May; 13(5):1412-4. PubMed ID: 11961032
    [No Abstract]   [Full Text] [Related]  

  • 4. Anemia management protocols and epoetin alfa administration: an algorithm approach. Case study of the anemic patient.
    Aiello J
    Nephrol Nurs J; 2002 Jun; 29(3):297-300. PubMed ID: 12164081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of erythropoietin in the treatment of cancer-related anemia].
    Huang JX; Meng FJ
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):877-8. PubMed ID: 22335959
    [No Abstract]   [Full Text] [Related]  

  • 6. Case management of the anemic patient. Epoetin alfa: focus on iron management.
    Kirlin LF
    ANNA J; 1990 Jun; 17(3):256-7. PubMed ID: 2357123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical administration of epoetin alfa recombinant.
    Taylor BA; Weinstein SM
    J Intraven Nurs; 1992; 15(2):78-82. PubMed ID: 1564606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of recombinant erythropoietin therapy for renal transplantation.
    Ward HJ
    Am J Nephrol; 1990; 10 Suppl 2():44-7; discussion 48-52. PubMed ID: 2260618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regarding impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysis.
    Tonelli M; Owen WF; Jindal K; Winkelmayer WC; Manns B
    Kidney Int; 2004 Oct; 66(4):1712; author reply 1712-3. PubMed ID: 15458473
    [No Abstract]   [Full Text] [Related]  

  • 10. Anemia treatment with erythropoietin in pregnant renal recipients.
    Cyganek A; Pietrzak B; Kociszewska-Najman B; Sanko-Resmer J; Paczek L; Wielgos M
    Transplant Proc; 2011 Oct; 43(8):2970-2. PubMed ID: 21996203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Personal experience with the use of human recombinant erythropoietin in the treatment of anemia in children with chronic renal insufficiency].
    Podracká L; Sasinka M; Roland R; Böör A
    Cesk Pediatr; 1992 May; 47(5):268-71. PubMed ID: 1638649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of darbepoetin alfa versus epoetin alfa for the treatment of chemotherapy induced anemia in patients with gynecologic malignancies.
    Case AS; Rocconi RP; Kilgore LC; Barnes MN
    Gynecol Oncol; 2006 Jun; 101(3):499-502. PubMed ID: 16406064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of patients' responses to epoetin alfa therapy.
    Krantz SB
    Pharmacotherapy; 1990; 10(2 ( Pt 2)):15S-21S. PubMed ID: 2189124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DOQI Guidelines/fifth in a series. A focus on iron management for better HcTs.
    Nephrol News Issues; 1997 Sep; 11(9):39, 53. PubMed ID: 9348872
    [No Abstract]   [Full Text] [Related]  

  • 15. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
    Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
    Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
    Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
    J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of recombinant human erythropoietin on erythrocyte lines in patients with anemia and chronic renal insufficiency].
    Marisavljević D; Djukanović Lj; Lezajić V
    Srp Arh Celok Lek; 1992; 120(9-10):281-5. PubMed ID: 1306020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to consider the role of epoetin.
    Zhang Y; Thamer M
    Kidney Int; 2006 May; 69(10):1917; author reply 1917-8. PubMed ID: 16688199
    [No Abstract]   [Full Text] [Related]  

  • 19. IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000.
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 1):S182-238. PubMed ID: 11229970
    [No Abstract]   [Full Text] [Related]  

  • 20. [Iron deficiency and anemia in oncology].
    Scotté F; Launay-Vacher V; Ray-Coquard I
    Bull Cancer; 2012 May; 99(5):563-70. PubMed ID: 22516641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.